House Energy Subcommittee Issues Testimony From Biotechnology Innovation Organization Chief Scientific Officer Esham
May 10, 2022
May 10, 2022
WASHINGTON, May 10 -- The House Energy and Commerce Subcommittee on Health issued the following testimony by Cartier Esham, chief scientific officer of the Biotechnology Innovation Organization, involving a hybrid hearing on March 17, 2022, entitled "The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight":
* * *
My name is Cartier Esham, and I am the Chief Scientific Officer at the Biotechnology Innovation Organization, or BIO. BIO a . . .
* * *
My name is Cartier Esham, and I am the Chief Scientific Officer at the Biotechnology Innovation Organization, or BIO. BIO a . . .